Aequus Pharmaceuticals (AQSZF)

[BioSpecialist]

MC $20M /MEGA Pipeline /Close to Profitability /Cash until mid 2018 =TOP PICK 2017

AQSZF is close to profitability and to file 3 NDA and the whole company is valued at ridiculous $20 Million .This Stock should be at minimum $2+ right now .

http://www.aequuspharma.ca/Investors/AQS%20investor%20November%202016_web.pdf

File for CDN approval of Topiramate XR and Oxcarbazepine XR in 1H 2017

Operational profitability estimated in 2017

Additional Product Deals in 2017

Partnership for AQS1301 in 2017

Two products launches to date (Tacrolimus IR and Vistitan™)

3 long-acting, transdermal programs in development, on track to file NDA in 2018


MUST Watch